Cairo Univeristy
Multiple Locations, Giza Governorate, 12613, Egypt
NCT Number: NCT05903144
Manual noninvasive respiratory techniques gained interest to treat respiratory pathologies related to COVID 19. This study designed to determine the combined effect of manual diaphragmatic release technique with the effect of conventional breathing exercises and prone positioning on pulmonary function parameters (FVC, FEV1, PEF, FEV1/FVC, FEF25, FEF50, FEF75, FEF25/75).
Looking for future studies?
Notify Me35 year–45 year
Female
Interventional
Not applicable
Multiple Locations, Giza Governorate, 12613, Egypt
Forty females were randomly assigned to two groups. Group A received manual diaphragm release with conventional breathing exercises and prone positioning. Group B received conventional breathing exercises and prone positioning. Both groups took their prescribed medications. Their ages ranged from 35 to 45 years and with moderate COVID-19 illness. Any cases with mild and severe COVID-19 illness, ICU admission, and chest diseases were excluded.
Main measures: pulmonary function parameters (FVC, FEV1, PEF, FEV1/FVC, FEF25, FEF50, FEF75, FEF25/75).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
manual diaphragmatic release technique combined with breathing exercise
deep breathing exercise and prone position
Time frame: pre study and 3 weeks post study for all participants
the amount of air that can be forcibly exhaled from your lungs after taking the deepest breath possible which is a common breathing test to check lung function.
Time frame: pre study and 3 weeks post study for all participants
the maximum amount of air that the subject can forcibly expel during the first second following maximal inhalation
Time frame: pre study and 3 weeks post study for all participants
show the amount and rate of air that can be forcefully breathed out of the lungs.
Time frame: pre study and 3 weeks post study for all participants
FEV1/FVC, also known as FEV1%) can help distinguish obstructive and restrictive lung diseases.
Time frame: pre study and 3 weeks post study for all participants
Peak expiratory flow at 25% of fvc and the most sensitive measure of airflow in peripheral airways where primary airflow obstruction originates.
Time frame: pre study and 3 weeks post study for all participants
Peak expiratory flow at 50% ofFVC
Time frame: pre study and 3 weeks post study for all participants
Peak expiratory flow at 75% of FVC
Time frame: pre study and 3 weeks post study for all participants
Maximum flow rate in the middle 50% of forced expiration.
Cairo University
Other
Influence of Manual Diaphragm Release Combined With Conventional Breathing Exercises and Prone Positioning on Pulmonary Functions in Women With COVID-19
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05765396
COVID-19, COVID-19 Pneumonia
Fort Sam Houston, Texas, United States
View Trial DetailsNCT07656610
COVID-19, COVID-19 Pneumonia
Çorum, Turkey (Türkiye)
View Trial DetailsNCT05392075
COVID-19, COVID-19 Pneumonia
Dallas, Texas, United States
View Trial DetailsNCT05408312
COVID-19, COVID-19 Pneumonia
Shangqiu, Henan, China
View Trial Details